• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Toshiba’s DCA technique

Article

Toshiba America Medical Systems of Tustin, CA, has received 510(k)clearance for its Directional Color Angio (DCA) technique forthe PowerVision ultrasound scanner (SCAN Special Report 12/96).DCA combines color ultrasound angio images with directional

Toshiba America Medical Systems of Tustin, CA, has received 510(k)clearance for its Directional Color Angio (DCA) technique forthe PowerVision ultrasound scanner (SCAN Special Report 12/96).DCA combines color ultrasound angio images with directional blood-flowinformation from conventional color Doppler, allowing cliniciansto determine tissue perfusion and differentiate between arterialand venous blood flow. DCA is a standard feature on PowerVisionscanners.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.